{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:47:06Z","timestamp":1773287226004,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/20404-0, 2018\/19083-7"],"award-info":[{"award-number":["2017\/20404-0, 2018\/19083-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Monoclonal antibodies (mAbs) have been a valuable tool to elucidate several biological processes, such as stem cell differentiation and cancer, and contributed to virtually all areas of biomedical sciences. Yet, it remains a challenge to obtain mAbs specific to poorly expressed epitopes, or to epitopes that are actually involved in important biological phenomena, such as cell differentiation and metastasis. Drug-induced subtractive immunization, and recently the multiple tolerization subtractive immunization (MTSI) technique, reported by our group, have the potential to level up the field, as they direct the host\u00b4s immune response towards these epitopes. However, due to cyclophosphamide (CY) treatment, high mice mortality can be observed, and only a few data are available on how these techniques affect the immune system of mice. Tolerogen and immunogen cells, RWPE-1 and PC-3 cells, respectively, were individually seeded at 2\u00a0\u00d7 10<jats:sup>4<\/jats:sup> cells\/cm<jats:sup>2<\/jats:sup>, and then adjusted to 2 \u00d7 10<jats:sup>6<\/jats:sup> cells per mouse before immunization, which was conducted in a subtractive approach (MTSI) with CY. Immunosuppression of mice was recorded <jats:italic>via<\/jats:italic> total white blood counting, as well the reactivity of circulating polyclonal antibodies (pAbs). General parameters, including weight, physical appearance, and behavior on mice subjected to three different concentrations of CY were recorded. mAbs were obtained using classical hybridoma techniques, using the spleen of immunized mice. After purification, antibodies were characterized by Western blotting, and Indirect immunofluorescence. In conclusion, all CY dosage were efficient in creating an immunosuppression state, but only the 100 mg\/kg body weight was feasible, as the others resulted in extensive mice mortality. pAbs obtained in the peripheral blood of mice showed more reactivity towards tumor cells. MAbs 2-7A50 and 2-5C11 recognized antigens from tumor cells, but not from their non-tumor counterparts, as shown in western blotting and immunofluorescence assays. MTSI technique was successful in generating mAbs that recognize tumor-specific antigens.<\/jats:p>","DOI":"10.3389\/fimmu.2021.760817","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T12:11:50Z","timestamp":1638879110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Multiple Tolerization Subtractive Immunization (MTSI) Protocol: Effects on Mice and Monoclonal Antibody Specificity"],"prefix":"10.3389","volume":"12","author":[{"given":"Marina","family":"de Lima Fontes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciny Mara de Lima","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin Sousa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Marisa","family":"Fusco-Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9 Soares Mendes","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Luis","family":"Felisbino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elenice","family":"Deffune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/256495a0","article-title":"Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2014.09.001","article-title":"The History of Monoclonal Antibody Development \u2013 Progress, Remaining Challenges and Future Innovations","volume":"3","author":"Liu","year":"2014","journal-title":"Ann Med Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v16i3.29","article-title":"Monoclonal Antibodies: A Review of Therapeutic Applications and Future Prospects","volume":"3","author":"Mahmuda","year":"2017","journal-title":"Trop J Pharm Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1556465","article-title":"Antibodies to Watch in 2019","volume":"2","author":"Kaplon","year":"2019","journal-title":"MAbs"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.03.004","article-title":"Antibodies and Associates: Partners in Targeted Drug Delivery","volume":"177","author":"Kennedy","year":"2017","journal-title":"Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3930","article-title":"Building Better Monoclonal Antibody-Based Therapeutics","volume":"6","author":"Weiner","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7150\/thno.37443","article-title":"Monoclonal Antibody-Based Molecular Imaging Strategies and Theranostic Opportunities","volume":"2","author":"Dammes","year":"2020","journal-title":"Theranostics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00441-008-0632-6","article-title":"Development of a Decoy Immunization Strategy to Identify Cell-Surface Molecules Expressed on Undifferentiated Human Embryonic Stem Cells","volume":"333","author":"Choi","year":"2008","journal-title":"Cell Tissue Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.00766","article-title":"Identification and Validation of Cell Surface Antigens for Antibody Targeting in Oncology","volume":"11","author":"Carter","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/jcm8081092","article-title":"Markers of Cancer Cell Invasion: Are They Good Enough","volume":"8","author":"Gerashchenko","year":"2019","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2008.08.011","article-title":"Antibody-Based Identification of Cell Surface Antigens: Targets for Cancer Therapy","volume":"8","author":"Loo","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00357-7","article-title":"Targeting the Proteome\/Epitome, Implementation of Subtractive Immunization","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0022-1759(87)90174-8","article-title":"Cyclophosphamide Treatment Used to Manipulate the Immune Response for the Production of Monoclonal Antibodies","volume":"100","author":"Matthew","year":"1987","journal-title":"J Immunol Methods"},{"key":"B14","article-title":"Subtractive Immunization Techniques for the Production of Monoclonal Antibodies to Rare Antigens","volume":"6","author":"Williams","year":"1992","journal-title":"Biotechniques"},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/19420862.2017.1331804","article-title":"Enhanced Immunization Techniques to Obtain Highly Specific Monoclonal Antibodies","volume":"10","author":"de Almeida","year":"2018","journal-title":"MAbs"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2017.0055","article-title":"Multiple Tolerization Reduces Antibody Binding Against Tolerogen Cells: Implications for the Production of Monoclonal Antibodies","volume":"37","author":"de Almeida","year":"2018","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"B17","article-title":"Cytotoxicity, DNA Cross-Linking, and Single Strand Breaks Induced by Activated Cyclophosphamide and Acrolein in Human Leukemia Cells","volume":"46","author":"Crook","year":"1986","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0162-3109(88)90039-2","article-title":"The Effect of Cyclophosphamide on B Cells and \u2019Background\u2019 Immunoglobulin-Secreting Cells in Mice","volume":"15","author":"Sabbele","year":"1988","journal-title":"Immunopharmacology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(02)00788-9","article-title":"Mobilization by Either Cyclophosphamide or Granulocyte Colony-Stimulating Factor Transforms the Bone Marrow Into a Highly Proteolytic Environment","volume":"30","author":"L\u00e9vesque","year":"2002","journal-title":"Exp Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tox.2006.01.027","article-title":"Cyclophosphamide Treatment Causes Impairment of Sperm and Its Fertilizing Ability in Mice","volume":"222","author":"Elangovan","year":"2006","journal-title":"Toxicology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.micres.2014.11.002","article-title":"Effects of Cyclophosphamide on Immune System and Gut Microbiota in Mice","volume":"171","author":"Xu","year":"2015","journal-title":"Microbiol Res"},{"key":"B22","first-page":"96","article-title":"Practical Murine Hematopathology: A Comparative Review and Implications for Research","volume":"65","author":"O\u2019Connell","year":"2015","journal-title":"Comp Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1187","article-title":"Strategies for Discovering Novel Cancer Biomarkers Through Utilization of Emerging Technologies","volume":"5","author":"Kulasingam","year":"2008","journal-title":"Natural Clin Pract"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2018.1479740","article-title":"Challenges With Biomarkers in Cancer Drug Discovery and Development","volume":"13","author":"Dumbrava","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.122.6.1351","article-title":"Subtractive Immunization Yields Monoclonal Antibodies That Specifically Inhibit Metastasis","volume":"122","author":"Brooks","year":"1993","journal-title":"J Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206220","article-title":"Subtractive Immunization Using Highly Metastatic Human Tumor Cells Identifies SIMA135\/CDCP1, A 135 kDa Cell Surface Phosphorylated Glycoprotein Antigen","volume":"12","author":"Hooper","year":"2003","journal-title":"Oncogene"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-335-6_16","article-title":"Surface-Epitope Masking (SEM): An immunological Subtraction Approach for Developing Monoclonal Antibodies Targeting Surface-Expressed Molecules","volume":"383","author":"Goldstein","year":"2007","journal-title":"Methods Mol Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.760817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T12:45:17Z","timestamp":1638881117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.760817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2021.760817"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.760817","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"article-number":"760817"}}